iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
終値時点
$1.13
+$0.04 · +3.67%
時間外
$1.0812
−$0.0488 · -4.32%
10月9日 19:42 ET
日中の時刻はETです。市場データは遅延する場合があります。
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
日中レンジ
現在 $1.13
52週レンジ
現在 $1.13
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
16
著しい割高
センチメント
52
まちまち
リスク
74
高リスク
モメンタム
17
強い下落
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
日中レンジ
現在 $1.13
52週レンジ
現在 $1.13
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 192.9万 USD | 929.11万 USD | 992.82万 USD | 1040.23万 USD | 1113.53万 USD |
| 売上原価 | 190.49万 USD | 530.27万 USD | 482.03万 USD | 475.7万 USD | 524.9万 USD |
| 粗利益 | 2.41万 USD | 398.84万 USD | 510.79万 USD | 564.53万 USD | 588.63万 USD |
| 研究開発 | 215.98万 USD | 353.03万 USD | 356.69万 USD | 265.63万 USD | 183.79万 USD |
| 販売・一般管理 | 659.52万 USD | 1264.83万 USD | 1167.99万 USD | 1237.4万 USD | 939.97万 USD |
| 営業費用 | 900.2万 USD | 1671.64万 USD | 1627.73万 USD | 1583.14万 USD | 1181.15万 USD |
| 受取利息 | 3748 USD | 4.41万 USD | 33.98万 USD | 16.93万 USD | 1.14万 USD |
| 支払利息 | 1949 USD | 22.01万 USD | 23.08万 USD | 23.9万 USD | 210.27万 USD |
| 減価償却費と償却費 | 173.09万 USD | 229.42万 USD | 211.51万 USD | 120.52万 USD | 100.4万 USD |
| 営業利益 | −897.79万 USD | −1272.8万 USD | −1116.93万 USD | −1018.61万 USD | −592.52万 USD |
| 純利益 | −1048.75万 USD | −1249.78万 USD | −1109.95万 USD | −1024.59万 USD | −896.18万 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。